| Literature DB >> 34350260 |
Yuming Chong1, Xiao Long1, Yuh-Shan Ho2.
Abstract
BACKGROUND: Keloids remain troublesome for clinicians because of the lack of standard therapy, and the underlying mechanisms are still unclear. Bibliometric analysis could be a powerful tool to comprehensively review research trends, evaluate publication performances and provide future perspectives. There is no bibliometric analysis focusing on keloid research.Entities:
Keywords: Keloid; Web of Science Core Collection; bibliometric; citation analysis; research trends
Year: 2021 PMID: 34350260 PMCID: PMC8263893 DOI: 10.21037/atm-21-508
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Citations and authors according to document type
| Document type |
| % |
|
|
|
|
|---|---|---|---|---|---|---|
| Article | 2,253 | 66 | 11,288 | 5.0 | 48,426 | 21 |
| Meeting abstract | 489 | 14 | 2,185 | 4.5 | 190 | 0.39 |
| Review | 264 | 7.8 | 1,025 | 3.9 | 11,208 | 42 |
| Letter | 257 | 7.6 | 826 | 3.2 | 1,315 | 5.1 |
| Proceedings’ paper | 97 | 2.9 | 418 | 4.3 | 3,361 | 35 |
| Editorial material | 88 | 2.6 | 238 | 2.7 | 343 | 3.9 |
| Correction | 21 | 0.62 | 84 | 4.0 | 7 | 0.33 |
| Note | 19 | 0.56 | 60 | 3.2 | 447 | 24 |
| Book chapter | 7 | 0.21 | 23 | 3.3 | 423 | 60 |
| Discussion | 1 | 0.029 | 1 | 1.0 | 4 | 4.0 |
| News item | 1 | 0.029 | 0 | 0 | 0 | 0 |
| Reprint | 1 | 0.029 | 3 | 3.0 | 1 | 1.0 |
TP, number of publications; AU, number of authors; APP, number of authors per publication; TC2019, the total number of citations from Web of Science Core Collection since publication year to the end of 2019; CPP2019, number of citations (TC2019) per publication (TP).
Figure 1Number of keloid articles and citations per publication by year.
The top 11 most productive journals
| Journal |
|
|
| Web of Science category | |
|---|---|---|---|---|---|
|
| 83 (3.7) | 2.567 | 4.0 | 33 | Dermatology; surgery |
|
| 81 (3.6) | 4.235 | 5.0 | 41 | Surgery |
|
| 58 (2.6) | 1.354 | 4.9 | 23 | Surgery |
|
| 56 (2.5) | 7.143 | 7.1 | 50 | Dermatology |
|
| 50 (2.2) | 7.000 | 5.8 | 35 | Dermatology |
|
| 48 (2.1) | 2.471 | 5.8 | 30 | Cell biology; dermatology; research and experimental medicine; surgery |
|
| 40 (1.8) | 2.067 | 4.3 | 16 | Dermatology |
|
| 39 (1.7) | 2.339 | 5.6 | 22 | Dermatology |
|
| 32 (1.4) | 3.368 | 6.1 | 19 | Dermatology |
|
| 30 (1.3) | 1.798 | 4.2 | 18 | Surgery |
|
| 30 (1.3) | 2.066 | 5.2 | 15 | Critical care medicine; dermatology; surgery |
TP, number of articles; %, the percentage of articles in total publications; IF2019, journal impact factor in 2019; APP, number of authors per publication; CPP2019, number of citations (TC2019) per publication (TP).
Top 15 productive countries/regions with six publication indicators and their CPP2019
| Countries/regions |
|
| ||||||
|---|---|---|---|---|---|---|---|---|
| USA | 608 | 1 (27) | 1 (24) | 1 (45) | 1 (24) | 1 (24) | 1 (45) | 34 |
| China | 341 | 2 (15) | 2 (15) | 2 (19) | 2 (14) | 2 (14) | 12 (1.6) | 10 |
| Japan | 202 | 3 (9.0) | 3 (8.4) | 5 (13) | 3 (8.1) | 3 (8.1) | 5 (3.9) | 29 |
| Germany | 177 | 4 (7.9) | 4 (6.1) | 4 (19) | 4 (6.1) | 4 (6.1) | 4 (4.7) | 29 |
| UK | 162 | 5 (7.2) | 5 (5.3) | 2 (19) | 5 (5.9) | 5 (5.6) | 2 (5.5) | 28 |
| South Korea | 128 | 6 (5.7) | 6 (5.3) | 8 (8.5) | 6 (5.0) | 6 (5.2) | 12 (1.6) | 13 |
| Italy | 95 | 7 (4.2) | 7 (3.2) | 6 (10) | 7 (3.4) | 7 (3.3) | 12 (1.6) | 22 |
| France | 70 | 8 (3.1) | 9 (2.8) | 12 (4.9) | 10 (2.6) | 9 (2.7) | 8 (2.3) | 24 |
| Brazil | 66 | 9 (2.9) | 10 (2.8) | 14 (3.9) | 9 (2.6) | 10 (2.6) | 19 (0.78) | 16 |
| India | 66 | 9 (2.9) | 8 (3.1) | 21 (2.0) | 8 (2.7) | 8 (2.8) | 8 (2.3) | 16 |
| Canada | 61 | 11 (2.7) | 14 (1.8) | 7 (8.8) | 12 (2.0) | 15 (2.1) | 6 (3.1) | 27 |
| Singapore | 56 | 12 (2.5) | 15 (1.5) | 8 (8.5) | 12 (2.0) | 14 (2.1) | 12 (1.6) | 32 |
| Netherlands | 52 | 13 (2.3) | 13 (1.9) | 11 (5.2) | 12 (2.0) | 11 (2.1) | N/A | 22 |
| Taiwan | 50 | 14 (2.2) | 12 (2.1) | 17 (3.3) | 11 (2.2) | 11 (2.1) | 19 (0.78) | 21 |
| Turkey | 48 | 15 (2.1) | 11 (2.2) | 21 (2.0) | 12 (2.0) | 11 (2.1) | 2 (5.5) | 13 |
TP, number of total articles; IP, single-country articles; CP, internationally collaborative articles; FP, first-author articles; RP, corresponding-author articles, SP, single-author articles; R, rank; CPP2019, number of citations (TC2019) per publication (TP); N/A, not available.
Figure 2Comparison of the growth trends of the top six productive countries (TP ≥128).
Top 15 productive institutions with six publication indicators and their CPP2019
| Institute |
|
| ||||||
|---|---|---|---|---|---|---|---|---|
| University of Manchester, UK | 56 | 1 (2.5) | 4 (1.2) | 1 (3.4) | 1 (2.0) | 1 (1.9) | 7 (0.78) | 32 |
| Shanghai Jiao Tong University, China | 45 | 2 (2.0) | 2 (1.3) | 2 (2.5) | 2 (1.5) | 2 (1.6) | N/A | 7.5 |
| National University of Singapore, Singapore | 41 | 3 (1.8) | 2 (1.3) | 5 (2.2) | 5 (1.0) | 4 (1.0) | N/A | 37 |
| Stanford University, USA | 37 | 4 (1.6) | 19 (0.54) | 3 (2.4) | 7 (0.89) | 7 (0.73) | 7 (0.78) | 34 |
| Yonsei University, South Korea | 34 | 5 (1.5) | 7 (0.86) | 6 (2.0) | 4 (1.2) | 5 (0.87) | N/A | 8.8 |
| University of Miami, USA | 31 | 6 (1.4) | 1 (1.8) | 14 (1.1) | 3 (1.2) | 3 (1.0) | 7 (0.78) | 51 |
| Harvard University, USA | 31 | 6 (1.4) | 153 (0.11) | 4 (2.3) | 23 (0.4) | 19 (0.41) | 2 (1.6) | 36 |
| Nippon Medical School, Japan | 28 | 8 (1.2) | 6 (1.0) | 8 (1.4) | 5 (1.0) | 5 (0.87) | 2 (1.6) | 22 |
| Fourth Military Medical University, China | 24 | 9 (1.1) | 12 (0.76) | 11 (1.3) | 9 (0.62) | 8 (0.64) | N/A | 16 |
| Chinese Academy of Medical Sciences, China | 23 | 10 (1.0) | 33 (0.32) | 7 (1.5) | 8 (0.76) | 9 (0.59) | N/A | 6.8 |
| Sungkyunkwan University, South Korea | 21 | 11 (0.93) | 12 (0.76) | 14 (1.1) | 14 (0.49) | 9 (0.59) | N/A | 12 |
| University of Southern California, USA | 20 | 12 (0.89) | 33 (0.32) | 11 (1.3) | 18 (0.45) | 23 (0.36) | N/A | 43 |
| University of California Los Angeles, USA | 19 | 13 (0.85) | 153 (0.11) | 9 (1.4) | 30 (0.36) | 30 (0.32) | 7 (0.78) | 36 |
| Peking Union Medical College, China | 18 | 14 (0.80) | N/A | 9 (1.4) | N/A | 36 (0.27) | N/A | 7.4 |
| Thomas Jefferson University, USA | 17 | 15 (0.76) | 7 (0.86) | 35 (0.68) | 11 (0.58) | 23 (0.36) | N/A | 55 |
TP, total number of highly cited articles; TPR (%), IPR (%), CPR (%), FPR (%), RPR (%), and SPR (%), the rank and percentage of total articles, single-institution articles, inter-institutionally collaborative articles, first-author articles, corresponding-author articles, single-author articles in their total articles; CPP2019, number of citations (TC2019) per publication (TP); N/A, not available.
Figure 3Top 17 authors with Y-index (j ≥10).
Figure 4The citation histories of the 11 highly cited keloid articles with TC2019 ≥216.
Figure 5The citation histories of the 10 most impact keloid articles in 2019 with C2019 22.
Top 20 most frequently used substantives in title during the past three decades
| Words in title |
| Rank (%) | |||
|---|---|---|---|---|---|
| 1990–2019 | 1990–1999 | 2000–2009 | 2010–2019 | ||
| Keloid | 768 | 1 (34) | 1 (27) | 1 (30) | 1 (38) |
| Keloids | 465 | 2 (21) | 2 (22) | 2 (22) | 2 (19) |
| Treatment | 347 | 3 (15) | 4 (16) | 4 (13) | 3 (16) |
| Fibroblasts | 307 | 4 (14) | 6 (13) | 3 (14) | 4 (14) |
| Scars | 300 | 5 (13) | 3 (16) | 5 (12) | 5 (13) |
| Hypertrophic | 228 | 6 (10) | 4 (16) | 6 (12) | 9 (7.7) |
| Expression | 200 | 7 (8.9) | 11 (6.4) | 7 (10) | 6 (9.2) |
| Skin | 181 | 8 (8) | 8 (7.6) | 8 (7.8) | 8 (8.3) |
| Scar | 163 | 9 (7.2) | 9 (7) | 12 (4.9) | 7 (8.5) |
| Collagen | 148 | 10 (6.6) | 7 (8.2) | 10 (6.6) | 11 (6.1) |
| Human | 138 | 11 (6.1) | 10 (6.7) | 11 (5.4) | 10 (6.4) |
| Growth | 122 | 12 (5.4) | 17 (3.2) | 9 (6.9) | 12 (5.2) |
| Therapy | 97 | 13 (4.3) | 28 (2.3) | 21 (3.6) | 12 (5.2) |
| Laser | 88 | 14 (3.9) | 33 (2) | 21 (3.6) | 14 (4.6) |
| Intralesional | 87 | 15 (3.9) | 20 (2.9) | 16 (3.7) | 15 (4.2) |
| Surgical | 86 | 16 (3.8) | 33 (2) | 13 (4.2) | 16 (4.1) |
| Clinical | 83 | 17 (3.7) | 33 (2) | 15 (4) | 18 (3.9) |
| Patients | 83 | 17 (3.7) | 14 (3.5) | 16 (3.7) | 22 (3.7) |
| Formation | 81 | 19 (3.6) | 20 (2.9) | 16 (3.7) | 22 (3.7) |
| Proliferation | 78 | 20 (3.5) | 45 (1.7) | 24 (3.1) | 16 (4.1) |
TP, occurrence times of substantives in title during 1990 to 2019.
Figure 6The progression of research hotspots in the recent three decades.